U.S. flag An official website of the United States government
  1. Home
  2. News & Events
  3. FDA Meetings, Conferences and Workshops
  4. Public Calendar - Meetings With FDA Officials
  5. Public Calendar: April 16 - 22, 2017
  1. FDA Meetings, Conferences and Workshops

Public Calendar: April 16 - 22, 2017

This public calendar is issued by the Food and Drug Administration. It lists significant meetings held by designated FDA policy makers with persons outside the executive branch of the Federal Government.

Official Name : Stephen M. Ostroff, M.D., Acting Commissioner of Food and Drugs

Event Date : 04/19/2017 - 04/19/2017
Location : Atlanta, GA
Subject : Panel Discussion on Administration Efforts to Address the Prescription Drug Abuse and Heroin Epidemics
FDA Participant/Group : N/A
Non FDA Participant/Group : N/A

Official Name : Anna Abram, Deputy Commissioner for Policy, Planning, Legislation, and Analysis

No Significant Event

Official Name : Dara Corrigan, Acting Deputy Commissioner for Global Regulatory Operations and Policy

No Significant Event

Official Name : Jim Sigg, Acting Deputy Commissioner for Operations

No Significant Event

Official Name : Erik Mettler, Acting Deputy Commissioner for Foods and Veterinary Medicine

No Significant Event

Official Name : Melinda Plaisier, Associate Commissioner for Regulatory Affairs

No Significant Event

Official Name : Peter Lurie, M.D., M.P.H., Associate Commissioner for Policy and Planning

No Significant Event

Official Name : Mary Lou Valdez, M.S.M., Associate Commissioner for International Programs

No Significant Event

Official Name : Jack Kalavritinos, Associate Commissioner for External Affairs

No Significant Event

Official Name : Janice Soreth, Associate Commissioner for Special Medical Programs

No Significant Event

Official Name : Luciana Borio, M.D., Acting Chief Scientist

No Significant Event

Official Name : Janet Woodcock, M.D., Director, Center for Drug Evaluation and Research

No Significant Event

Official Name : Peter Marks, M.D., Ph.D., Director, Center for Biologics Evaluation and Research

Event Date : 04/18/2017 - 04/18/2017
Location : College Park, MD
Subject : Patient-Focused Drug Development(PFDD)
FDA Participant/Group : N/A
Non FDA Participant/Group : N/A

Official Name : Jeffrey Shuren, M.D., J.D., Director, Center for Devices and Radiological Health

No Significant Event

Official Name : Susan T. Mayne Ph.D., Director, Center for Food Safety and Applied Nutrition

No Significant Event

Official Name : Mitchell R. Zeller, J.D., Director, Center for Tobacco Products

Event Date : 04/19/2017
Location : Ottawa, Canada
Subject : Global Tobacco Regulators Forum
FDA Participant/Group : DAVID ASHLEY; MITCHELL ZELLER; CAITLIN ADDORISIO;
Non FDA Participant/Group : Several Represenatives from World Health Organization/Health Canada

Official Name : Steven Solomon, Director, Center for Veterinary Medicine

No Significant Event

Official Name : William Slikker, Jr., Ph.D., Director, National Center for Toxicological Research

No Significant Event

Official Name : Elizabeth H. Dickinson, Esq., Chief Counsel

Event Date : 04/18/2017 - 04/18/2017
Location : Silver Spring, MD
Subject : Natco Pharma Limited, Abbreviated New Drug Application(ANDA)
FDA Participant/Group : MARY HIATT; MAARIKA KIMBRELL; KIM DETTELBACH; MARTIN SHIMER; CHRISTOPHER PRUITT; ERIN KEPPLINGER; MARYLL TOUFANIAN;
Non FDA Participant/Group : Lara FitzSimmons, Trang Hoang, William Rakoczy (Rakoczy Molino Mazzochi Siwik LLP); Pramod Dahibhate, Sofia Mumtaz (Lupin Pharmaceuticals);